Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.

PloS one - 1 Jan 2013

Eskici Gözde, Gur Mert

Abstract excerpt

Alzheimer's disease is the most common form of dementia. It is a neurodegenerative and incurable disease that is associated with the tight packing of amyloid fibrils. This packing is facilitated by the compatibility of the ridges and grooves on the amyloid surface. The GxMxG motif is the major fa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Motifs
Share to Amyloid beta-Peptides
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Docking Simulation

Share to Molecular Dynamics Simulation

Share to Oligopeptides

Share to Peptide Fragments

Share to Thermodynamics

Source

Open in PubMed Open full text

Identifiers

PMID: 23762479
DOI: 10.1371/journal.pone.0066178
PMCID: PMC3675214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23762479-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.PMID 23762479Read ↗

Mutations in the Aβ42 Recognition Sequence KLVFF Afford New Pentapeptide Inhibitors of Aβ42 Fibrillation: Computation-Driven Rational Design and Experimental Validation.Semantic proximity Read ↗

<i>In Silico</i> Design of APOE ɛ4 Interaction Inhibitor Peptides for Alzheimer’s DiseaseSemantic proximity Read ↗

Alzheimer's Disease Immunotherapy and Mimetic Peptide Design for Drug Development: Mutation Screening, Molecular Dynamics, and a Quantum Biochemistry Approach Focusing on Aducanumab::Aβ2-7 Binding Affinity.Semantic proximity Read ↗

Computationally derived structural models of the beta-amyloid found in Alzheimer's disease plaques and the interaction with possible aggregation inhibitors.Semantic proximity Read ↗

Can molecular dynamics simulations assist in design of specific inhibitors and imaging agents of amyloid aggregation? Structure, stability and free energy predictions for amyloid oligomers of VQIVYK, MVGGVV and LYQLEN.Semantic proximity Read ↗

AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein FibrilsSemantic proximity Read ↗

Natural inhibitors of DYRK1A as drug candidates against Alzheimer Disease: QSAR, molecular docking, molecular dynamics simulation and drug evaluation assessmentSemantic proximity Read ↗

Rational design of complementary peptides to the betaAmyloid 29-42 fusion peptide: an application of PepDesign.Semantic proximity Read ↗

Computer-aided design of amino acid-based therapeutics: a reviewSemantic proximity Read ↗

Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants.Semantic proximity Read ↗

Design of amyloidogenic peptide trapsSemantic proximity Read ↗

“Common-Precursor” Protein Mimetic Approach to Rescue Aβ Aggregation-Mediated Alzheimer’s PhenotypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.